PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
33.01%
Revenue growth 1.25-1.5x 4997.T's 23.89%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
2.27%
Gross profit growth under 50% of 4997.T's 16.20%. Michael Burry would be concerned about a severe competitive disadvantage.
3437.74%
Positive EBIT growth while 4997.T is negative. John Neff might see a substantial edge in operational management.
-90.62%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
1636.83%
Positive net income growth while 4997.T is negative. John Neff might see a big relative performance advantage.
1636.88%
Positive EPS growth while 4997.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1636.88%
Positive diluted EPS growth while 4997.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-93.78%
Negative 10Y revenue/share CAGR while 4997.T stands at 56.67%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-37.77%
Negative 5Y CAGR while 4997.T stands at 40.87%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-30.47%
Negative 3Y CAGR while 4997.T stands at 27.49%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
115.89%
Positive 10Y CAGR while 4997.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
197.59%
Positive 5Y CAGR while 4997.T is negative. John Neff might view this as a strong mid-term relative advantage.
355.48%
Positive short-term CAGR while 4997.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
184.50%
5Y equity/share CAGR above 1.5x 4997.T's 39.30%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.65%
3Y equity/share CAGR above 1.5x 4997.T's 15.73%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.26%
Our AR growth while 4997.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
159.90%
Inventory growth well above 4997.T's 6.13%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
92.27%
Asset growth above 1.5x 4997.T's 2.53%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
13.38%
BV/share growth above 1.5x 4997.T's 0.57%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
331.15%
We have some new debt while 4997.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Our R&D shrinks while 4997.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
99.74%
SG&A growth of 99.74% while 4997.T is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.